Cullinan Therapeutics, Inc. (CGEM)
8.89
-0.18
(-1.98%)
USD |
NASDAQ |
Nov 20, 16:00
8.91
+0.02
(+0.22%)
After-Hours: 20:00
Cullinan Therapeutics Cash and Short Term Investments (Annual) : 377.90M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 377.90M |
| December 31, 2024 | 398.98M |
| December 31, 2023 | 467.07M |
| December 31, 2022 | 467.29M |
| Date | Value |
|---|---|
| December 31, 2021 | 290.47M |
| December 31, 2020 | 210.21M |
| December 31, 2019 | 98.63M |
| December 31, 2018 | 33.83M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Climb Bio, Inc. | 101.08M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |
| Sarepta Therapeutics, Inc. | 939.65M |
| Anixa Biosciences, Inc. | 15.17M |